<DOC>
	<DOCNO>NCT00336375</DOCNO>
	<brief_summary>The purpose explorative clinical trial study parasite population dynamic , diversity clearance kinetics Plasmodium falciparum well determination molecular mechanism associate drug resistance early phase artemether-lumefantrine treatment drug intake either accompany without intake fatty food . The hypothesis intake fatty food together artemether-lumefantrine enhance parasite clearance thereby decrease risk early selection genetic marker relate drug resistance . The study population child age 1-10 year uncomplicated malaria Bagamoyo District , Tanzania . Enrolled child randomly allocate either intake fatty meal together study drug . Artemether-lumefantrine give twice daily 3 day standard dos accord bodyweight . Study participant admit study period ( 3 day ) allow close supervision detail blood sampling .</brief_summary>
	<brief_title>Treatment Uncomplicated Childhood Malaria Tanzania Artemether+Lumefantrine - Efficacy Genotyping</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<criteria>Age 110 year Presence asexual P. falciparum parasitaemia 2000200 000/μL No general danger sign severe malaria present Haemoglobin ≥70 g/L History fever within 24 hour OR axillary temperature ≥ 37.5Cº No cause fever detectable No severe malnutrition Guardian/patient understood procedure study willing participate Not able drink breastfeed Vomiting everything Recent history convulsion Lethargic unconscious Unable sit stand ( appropriate age ) History allergy test drug History intake drug paracetamol aspirin within 3 day Symptoms/signs severe malaria</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>